Seguimiento de transacciones de insiders en los distintos mercados.
| 30 días | 90 días | 120 días | |
|---|---|---|---|
| Rentabilidad media | -9% | 8.2% | 15.1% |
| Tasa de éxito | 40% | 68% | 82% |
| Transacciones |
5
20% Comprar
|
34
71% Comprar
|
47
69% Comprar
|
| Rentabilidad media | 5% |
|---|---|
| Tasa de éxito | 73% |
| Período de tenencia promedio | 220 |
| Transacciones | 28 |
| Posición | Compañía | Período |
|---|---|---|
| Independent Director | Rhythm Pharmaceuticals Inc | 1 de abril de 2015 - |
| Member of the Supervisory Board | Eurobio Scientific SA | 27 de octubre de 2006 - |
| Special Advisor to the CEO | Ipsen SA | 1 de marzo de 2018 - 1 de enero de 2019 |
| Executive Vice President, Strategy Business Development | Ipsen SA | 1 de enero de 2016 - 1 de marzo de 2018 |
| Executive Vice President - Group Strategy and Business Development, Member of the Executive Committee | Ipsen SA | 2 de octubre de 2013 - 1 de enero de 2016 |
| Executive Vice President - Operations and Member of the Executive Committee | Ipsen SA | None - |
Buscar